Atlas Trials

Comparing Efficacy and Safety of CinnaGen Beta Erythropoietin (CinnaPoietin®) Versus Eprex® on the Treatment of Anemia in ESRD Hemodialysis Patients

Clinical trial NCT03408639 · COMPLETED

Trial details

NCT number
NCT03408639
Sponsor
Cinnagen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Anemia in End-Stage Renal Disease
Start date
2016-06-22
Primary completion
2017-07-19
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.